Welcome to LookChem.com Sign In|Join Free

CAS

  • or
phenol, 4-bromo-2-(2-propenyl)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

13997-74-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 13997-74-5 Structure
  • Basic information

    1. Product Name: phenol, 4-bromo-2-(2-propenyl)-
    2. Synonyms: 2-allyl-4-bromophenol;phenol, 4-bromo-2-(2-propenyl)-;4-bromo-2-prop-2-enylphenol;4-bromo-2-prop-2-enyl-phenol
    3. CAS NO:13997-74-5
    4. Molecular Formula: C9H9BrO
    5. Molecular Weight: 213.07116
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 13997-74-5.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 273.3°C at 760 mmHg
    3. Flash Point: 119.1°C
    4. Appearance: /
    5. Density: 1.435g/cm3
    6. Vapor Pressure: 0.00345mmHg at 25°C
    7. Refractive Index: 1.584
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: phenol, 4-bromo-2-(2-propenyl)-(CAS DataBase Reference)
    11. NIST Chemistry Reference: phenol, 4-bromo-2-(2-propenyl)-(13997-74-5)
    12. EPA Substance Registry System: phenol, 4-bromo-2-(2-propenyl)-(13997-74-5)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: IRRITANT
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 13997-74-5(Hazardous Substances Data)

13997-74-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 13997-74-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,9,9 and 7 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 13997-74:
(7*1)+(6*3)+(5*9)+(4*9)+(3*7)+(2*7)+(1*4)=145
145 % 10 = 5
So 13997-74-5 is a valid CAS Registry Number.
InChI:InChI=1/C9H9BrO/c1-2-3-7-6-8(10)4-5-9(7)11/h2,4-6,11H,1,3H2

13997-74-5Relevant articles and documents

Aluminium chloride-potassium iodide-acetonitrile system: A mild reagent system for aromatic claisen rearrangement at ambient temperature

Bhattacharyya, Nayan Kamal,Dutta, Deepjyoti,Biswas, Joydeep

, (2021)

Claisen rearrangement is used as the standard methods for the generation of complex organic substance. It is one of the well-known methods for the introduction of carbon-carbon bond. We have developed a protocol using allyl aryl ether as a substrate and AlCl3-KI as a mild reagent system and acetonitrile (CH3CN) is taken as solvent at ambient temperature. The reagent system presented in this current work is found to be appropriate for Claisen rearrangement of several aromatic alcohols with excellent yields.

Concise and practical approach for the synthesis of honokiol, a neurotrophic agent

Khan, P. Rasvan,Mujawar, Taufiqueahmed,Shankar, G.,Shekhar, P.,Subba Reddy, BV.,Subramanyam, Ravi

, (2020)

An improved method has been developed for the synthesis of honokiol using a readily available p-bromophenol as a precursor. The key step involved in this method is ortho-lithiation facilitated by methoxymethyl ether (MOM). Other important steps are ortho-allyl phenyl ether Claisen rearrangement and a Suzuki coupling for the construction of biaryls. This method does not require pre-functionalization of aromatic ring with bromide for the generation of arylboronic acid.

Discovery and SAR of Natural-Product-Inspired RXR Agonists with Heterodimer Selectivity to PPARδ-RXR

Nakashima, Ken-Ichi,Yamaguchi, Eiji,Noritake, Chihaya,Mitsugi, Yukari,Goto, Mayuki,Hirai, Takao,Abe, Naohito,Sakai, Eiji,Oyama, Masayoshi,Itoh, Akichika,Inoue, Makoto

, p. 1526 - 1534 (2020/05/19)

A known natural product, magnaldehyde B, was identified as an agonist of retinoid X receptor (RXR) α. Magnaldehyde B was isolated from Magnolia obovata (Magnoliaceae) and synthesized along with more potent analogs for screening of their RXRα agonistic activities. Structural optimization of magnaldehyde B resulted in the development of a candidate molecule that displayed a 440-fold increase in potency. Receptor-ligand docking simulations indicated that this molecule has the highest affinity with the ligand binding domain of RXRα among the analogs synthesized in this study. Furthermore, the selective activation of the peroxisome proliferator-activated receptor (PPAR) δ-RXR heterodimer with a stronger efficacy compared to those of PPARα-RXR and PPARγ-RXR was achieved in luciferase reporter assays using the PPAR response element driven reporter (PPRE-Luc). The PPARδactivity of the molecule was significantly inhibited by the antagonists of both RXR and PPARδ, whereas the activity of GW501516 was not affected by the RXR antagonist. Furthermore, the molecule exhibited a particularly weak PPARδagonistic activity in reporter gene assays using the Gal4 hybrid system. The obtained data therefore suggest that the weak PPARδagonistic activity of the optimized molecule is synergistically enhanced by its own RXR agonistic activity, indicating the potent agonistic activity of the PPARδ-RXR heterodimer.

Investigating the microwave-accelerated Claisen rearrangement of allyl aryl ethers: Scope of the catalysts, solvents, temperatures, and substrates

Hui, Zi,Jiang, Songwei,Qi, Xiang,Ye, Xiang-Yang,Xie, Tian

supporting information, (2020/05/18)

The microwave-accelerated Claisen rearrangement of allyl aryl ethers was investigated, in order to gain insight into the scope of the catalysts, solvents, temperatures, and substrates. Among the catalysts examined, phosphomolybdic acid (PMA) was found to greatly accelerate the reaction in NMP, at temperatures ranging from 220 to 300 °C. This method was found to be useful for preparing several intermediates previously reported in the literature using precious metal catalysts such as Au(I), Ag(I), and Pt(II). Additionally, substrates bearing bromo and nitro groups on the aryl portion required careful tailoring of the reaction conditions to avoid complex product profiles.

Palladium-Catalyzed Fluoroalkylative Cyclization of Olefins

Liao, Jianhua,Fan, Lianfeng,Guo, Wei,Zhang, Zhenming,Li, Jiawei,Zhu, Chuanle,Ren, Yanwei,Wu, Wanqing,Jiang, Huanfeng

supporting information, p. 1008 - 1011 (2017/03/15)

A palladium-catalyzed fluoroalkylative cyclization of olefins with readily available Rf-I reagents to afford the corresponding fluoroalkylated 2,3-dihydrobenzofuran and indolin derivatives with moderate to excellent yields is reported. This novel procedure provides an efficient method for the construction of Csp3-CF2 and C-O/N bonds in one step. A wide range of functional groups are tolerated. It is proposed that a radical/SET (single electron transfer) pathway proceeding via the fluoroalkyl radical may be involved in the catalytic cycle.

Method for Synthesizing 4-O-Methylhonokiol

-

Paragraph 0032-0034, (2016/12/22)

The present invention refers to a the active compounds useful 4-O-methylhonokiol-chemical method synthesis of relates to a preparation. Of the existing method according to the present invention extracted from natural 4-O the method obtaining-methylhonokiol produce highly pure crude high yield by a unidirectional photocoupler the product may be-methylhonokiol 4-O unit is off.

Synthesis of phosphorus containing medium ring heterocycles by sequential Claisen rearrangement and ring closing metathesis

Majumdar,Nandi, Raj Kumar,Ganai, Sintu

, p. 1247 - 1250 (2014/02/14)

An efficient method for the synthesis of novel medium ring phosphorus containing heterocycles starting from phenol derivatives by ruthenium catalyzed ring closing metathesis is described. This work deals with a sequential aromatic Claisen-rearrangement, coupling of an allyl/vinyl phosphonate, and ring closing metathesis reaction. All of these reactions were carried out at ambient temperature to afford the medium-sized phosphorus heterocycles in excellent yields.

Enantioselective synthesis of benzofurans and benzoxazines via an olefin cross-metathesis-intramolecular oxo-Michael reaction

Zhang, Jun-Wei,Cai, Quan,Gu, Qing,Shi, Xiao-Xin,You, Shu-Li

supporting information, p. 7750 - 7752 (2013/09/02)

Chiral phosphoric acid and Hoveyda-Grubbs II were found to catalyze an olefin cross-metathesis-intramolecular oxo-Michael cascade reaction of the ortho-allylphenols and enones to provide a variety of benzofuran and benzoxazine derivatives in moderate to good yields and enantioselectivity.

In vitro growth inhibition of human cancer cells by novel honokiol analogs

Lin, Jyh Ming,Prakasha Gowda,Sharma, Arun K.,Amin, Shantu

scheme or table, p. 3202 - 3211 (2012/07/28)

Honokiol possesses many pharmacological activities including anti-cancer properties. Here in, we designed and synthesized honokiol analogs that block major honokiol metabolic pathway which may enhance their effectiveness. We studied their cytotoxicity in human cancer cells and evaluated possible mechanism of cell cycle arrest. Two analogs, namely 2 and 4, showed much higher growth inhibitory activity in A549 human lung cancer cells and significant increase of cell population in the G0-G1 phase. Further elucidation of the inhibition mechanism on cell cycle showed that analogs 2 and 4 inhibit both CDK1 and cyclin B1 protien levels in A549 cells.

COMPOUND, ALPHA 1 ADRENALINE RECEPTOR ANTAGONIST, AND COMPOSITION

-

Page/Page column 14; 26, (2009/12/23)

A novel compound, a novel α1 adrenergic receptor antagonistic agent, and a novel composition are provided which are capable of exerting a therapeutic effect on treatment of hypertension as well as treatment of prostatic hypertrophy and the like. The compound is represented by the following formula (1):

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 13997-74-5